Comparative study between liver biopsy and non-invasive biomarkers in assessment of hepatic fibrosis in children with chronic liver diseases

被引:3
|
作者
Behairy, Ola Galal [1 ]
El-Shimi, Ola Samir [2 ]
Shalan, Naglaa Hamed [3 ]
机构
[1] Benha Univ, Fac Med, Pediat Dept, Banha, Egypt
[2] Benha Univ, Fac Med, Clin Pathol Dept, Banha, Egypt
[3] Benha Univ, Fac Med, Pathol Dept, Banha, Egypt
关键词
Chronic liver diseases; Children; Liver biopsy; Fibrosis; Non-invasive biomarkers; PLATELET RATIO INDEX; ASPARTATE-AMINOTRANSFERASE; PEDIATRIC-PATIENTS; DIAGNOSIS; CIRRHOSIS; PREDICT;
D O I
10.1186/s43054-021-00072-0
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Liver biopsy is the gold standard for detecting the degree of liver fibrosis; however, invasiveness constitutes its main limiting factor in clinical application, so we aimed to evaluate the non-invasive biomarker formulas (APRI and FIB-4) and their modified forms by BMI z-score (M-APRI, M-FIB-4, and B-AST) compared to liver biopsy in the assessment of liver fibrosis in children with chronic liver diseases. Two hundred children aged 6.3 +/- 3.8 years (98 males, 102 females) with chronic liver diseases underwent liver biopsy. The stage of fibrosis was assessed according to the METAVIR system for all children, and the following non-invasive biomarker formulas were calculated: APRI, modified APRI (M-APRI: BMI z-score x APRI), Fibrosis-4 index (FIB-4), modified FIB-4 (M-FIB-4: BMI z-score x FIB-4), and B-AST (BMI z-score x AST). The best cutoff value was calculated to detect early fibrosis (F1-F2) from advanced liver fibrosis (F3-F4). Results There were positive correlations between all studied non-invasive biomarker models (APRI, FIB-4, M-APRI, M-FIB-4, B-AST) and fibrosis score as an increase in fibrosis score was associated with an increase in mean +/- SD of all studied biomarker formulas. The best cutoff values of non-invasive biomarker models in the diagnosis of early fibrosis (F1-F2) were APRI > 0.96, M-APRI > 0.16, FIB-4 > 0.019, M-FIB-4 > 0.005, and B-AST > -8 with an area under the curve above 0.7 each, while the best cutoff values of non-invasive biomarker models (APRI, M-APRI, FIB-4, M-FIB-4, and B-AST) in the diagnosis of advanced liver fibrosis (F3-F4) were >1.96, >2.2, >0.045, and >0.015, >92.1, respectively, with an area under the curve above 0.8 each. Conclusion APRI, M-APRI, FIB-4, M-FIB-4, and B-AST are good non-invasive alternatives to liver biopsy in the detection of liver fibrosis in children with chronic liver diseases of different etiologies especially those that include BMI z-scores in their formulas.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Comparative study between liver biopsy and non-invasive biomarkers in assessment of hepatic fibrosis in children with chronic liver diseases
    Ola Galal Behairy
    Ola Samir El-Shimi
    Naglaa Hamed Shalan
    [J]. Egyptian Pediatric Association Gazette, 69
  • [2] Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: a prospective study
    Kessarin Thanapirom
    Sirinporn Suksawatamnuay
    Natthaporn Tanpowpong
    Bundit Chaopathomkul
    Supachaya Sriphoosanaphan
    Panarat Thaimai
    Nunthiya Srisoonthorn
    Sombat Treeprasertsuk
    Piyawat Komolmit
    [J]. Scientific Reports, 12
  • [3] Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: a prospective study
    Thanapirom, Kessarin
    Suksawatamnuay, Sirinporn
    Tanpowpong, Natthaporn
    Chaopathomkul, Bundit
    Sriphoosanaphan, Supachaya
    Thaimai, Panarat
    Srisoonthorn, Nunthiya
    Treeprasertsuk, Sombat
    Komolmit, Piyawat
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [4] Can non-invasive assessment of liver fibrosis replace liver biopsy?
    Yoshioka, Kentaro
    Hashimoto, Senju
    [J]. HEPATOLOGY RESEARCH, 2012, 42 (03) : 233 - 240
  • [5] Automated quantification of serum hyaluronic acid for non-invasive assessment of liver fibrosis in chronic hepatic diseases
    Lazarova, E. G. M.
    Fernandez, M. Y. V.
    Adler, M.
    Gulbis, B.
    [J]. IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2011, 26 (5-6): : 217 - 224
  • [6] ASSESSMENT OF LIVER FIBROSIS IN ALCOHOLIC LIVER DISEASE: NON-INVASIVE METHODS OR LIVER BIOPSY?
    de Ledinghen, V.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (08) : 41A - 41A
  • [7] Non-invasive assessment of liver fibrosis: reduce or substitute the need for liver biopsy?
    Chen, Yong-Peng
    Liang, Xie-Er
    [J]. LIVER INTERNATIONAL, 2015, 35 (11) : 2483 - 2483
  • [8] Non-invasive assessment of chronic liver and gastric diseases
    Plebani, Mario
    Basso, Daniela
    [J]. CLINICA CHIMICA ACTA, 2007, 381 (01) : 39 - 49
  • [9] Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms
    Sebastiani, Giada
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (18) : 2190 - 2203
  • [10] Non-invasive assessment of liver fibrosis in chronic liver diseases:Implementation in clinical practice and decisional algorithms
    Giada Sebastiani
    [J]. World Journal of Gastroenterology, 2009, 15 (18) : 2190 - 2203